EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lactylation in digestive system tumors: from mechanisms to therapeutic target

Jun Wei, Qian Ding, Hongjun Wang, Yang Liu

Frontiers in Oncology · 11.12.2025 · 15

DOI: 10.3389/fonc.2025.1607249 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 11.12.2025. Verfasst von Jun Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Jilin Medical University, Jilin, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lactylation, a recently identified epigenetic modification derived from lactate metabolism, has emerged as a key regulator linking cellular metabolic states to chromatin remodeling and gene transcription. Acting through histone and non-histone protein lactylation (for example, Histone H3 Lysine 9 Lactylation [H3K9la], Histone H3 Lysine 18 Lactylation [H3K18la]), this modification reshapes chromatin accessibility and activates transcriptional programs, thereby driving tumor progression, metabolic reprogramming, immune evasion, and chemoresistance in digestive system malignancies. This review comprehensively summarizes the latest advances in lactylation across esophageal cancer (EC), gastric cancer (GC), colorectal cancer (CRC), hepatocellular carcinoma (HCC), pancreatic cancer (PC), and gallbladder cancer (GBC), emphasizing its role in epigenetic regulation of oncogenic signaling and metabolic–epigenetic crosstalk. Moreover, we discuss potential biomarkers, therapeutic targets, and pharmacologic strategies aimed at modulating lactylation. Despite promising translational potential, key challenges remain in standardizing detection methods and validating clinical efficacy. The intricate mechanisms of lactylation not only deepen our understanding of digestive tumor biology but also unveil a rich landscape of novel therapeutic targets. Future investigations should focus on deciphering lactylation-mediated epigenetic mechanisms in tumor immunotherapy and precision medicine, providing new directions for research and clinical insights for the early diagnosis and tailored treatment of digestive system tumors.

Schlagwörter

Stichwörter der Autor:innen

digestive system tumorsepigenetic modificationlactylationtherapeutic targettumor metabolism

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Jilin Medical University, Jilin, China.
  • Edinburgh Medical School: Biomedical Sciences, College of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh, United Kingdom.
  • Zhejiang University-University of Edinburgh Institute, Zhejiang University School of Medicine, Haining, China.
  • Shanghai Fourth People's Hospital, School of Medicine, Tongji University, Shanghai, China.

Zitieren

APA

Wei, J., Ding, Q., Wang, H., & Liu, Y. (2025). Lactylation in digestive system tumors: from mechanisms to therapeutic target. Frontiers in Oncology, 15. https://doi.org/10.3389/fonc.2025.1607249

Vancouver

Wei J, Ding Q, Wang H, Liu Y. Lactylation in digestive system tumors: from mechanisms to therapeutic target. Frontiers in Oncology. 2025;15. doi:10.3389/fonc.2025.1607249

BibTeX
@article{Wei2025,
  author = {Wei, Jun and Ding, Qian and Wang, Hongjun and Liu, Yang},
  title = {Lactylation in digestive system tumors: from mechanisms to therapeutic target},
  journal = {Frontiers in Oncology},
  year = {2025},
  volume = {15},
  doi = {10.3389/fonc.2025.1607249}
}
Kostenlos starten →